Filter by:

Reset Filter
  • Life Sciences
Showing 1 - 12 of 62

2024 Antitrust in Healthcare

Anup Malani of the University of Chicago and James Lee of Cornerstone Research will discuss competition issues in healthcare and life sciences at this American Bar Association conference.


Entrenching and Leveraging Market Dominance in the 2023 Merger Guidelines: Insights from Amgen/Horizon

Insights from Amgen/Horizon merger on leveraging market dominance via bundling under 2023 Merger Guidelines.


How A 3-Firm ‘Joint Effort’ Beat A $3.6B Pharma Antitrust Suit

In this Law360 article, counsel discusses Celeste Saravia’s pivotal role as the economic expert in a pharmaceutical antitrust lawsuit.


Ciccio et al. v. SmileDirectClub LLC et al.

Class certification was denied in this false advertising matter.

Press Release

Brussels Team Expands with Experienced Competition Hire

Dr. Norbert Maier joins Cornerstone Research, with deep antitrust law and competition expertise from the EU Commission DG COMP team.


5 Questions with Sayeh Nikpay: The 340B Drug Pricing Program

Professor Sayeh Nikpay of the University of Minnesota discusses the role and implementation challenges of the 340B Drug Pricing Program.


Most-Favored Entry Clauses in Drug-Patent Litigation Settlements

The authors examine the competitive impacts of such clauses taking into account the regulatory structure and economics of the pharmaceutical industry in the United States.


Q&A with Joanna Tsai

WWL interviewed Joanna Tsai of Cornerstone Research about working at the FTC, the evolution of merger analysis, and her advice for aspiring competition economists.


The Global Antitrust Economics Conference

Rainer Schwabe and Anand Krishnamurthy will join competition experts to discuss the role of financial services and life sciences in antitrust.


Value Drug Company v. Takeda Pharmaceuticals U.S.A. Inc. et al.

Laurence Baker testified during a rare antitrust trial centering on the allegation that a brand manufacturer conspired with three generics to allocate the market for gout medication colchicine.


In re Novartis and Par Antitrust Litigation

Novartis reached settlements with plaintiffs in this reverse payment matter.

Press Release

Cornerstone Research Staff and Affiliated Experts Submit Comments on the Joint FTC-DOJ Draft Merger Guidelines

The Federal Trade Commission and the Department of Justice’s Antitrust Division launched a joint public inquiry to solicit comments from the public on the draft updated merger guidelines.

How can we help you?

If you are looking for a publication not on our website, contact us.